l General Information |
Product Name | Miltefosine |
General description | Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa, first oral drug for Visceral leishmaniasis, effective against both promastigotes and amastigotes. |
Purity | ≥98.0%(HPLC) | CAS Number | 58066-85-6 |
Formula | C21H46NO4P | Molecular Weight | 407.58 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White Solid |
Solubility(25°C) | DMSO | Slightly soluble |
Ethanol | ≥50mg/mL |
Water | ≥50mg/mL |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
